Laboratory：Hachioji
0 results
Selected search options |
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
- Oncomine Dx Target Test Multi-Research 46 Gene Analysis (FF)（Suspended beyond orders placed 12-28-2021）
Laboratory：Hachioji
○Oncomine Dx Target Test Multi-Research 46 Gene Analysis (FF)（Suspended beyond orders placed 12-28-2021）
CODE：R614 8
-
TEST NAME
SPECIMEN
REQUIREMENT
（ｍL） CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
Oncomine Dx Target Test Multi-Research 46 Gene Analysis (FF)（Suspended beyond orders placed 12-28-2021）
tissue
ARR
7-11 Next Generation Sequencing (NGS)
other material
COMMENT
The purpose of this study is to analyze BRAF gene V600E mutations, EGFR L858R mutations and EGFR exon 19 deletion mutations, ALK fusion gene, and ROS1 fusion gene in genomic DNA extracted from cancer tissues to determine the indications for the drugs listed in the attached table for patients with non-small cell lung cancer.
Available for pickup is Monday-Friday.
Please make sure that the material contains the tumor site before submitting it.
Please avoid duplicate requests of other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M961 0).
●About materials other than tissues
Please place the collected pleural fluid, alveolar lavage fluid, and bronchial lavage fluid for abrasion in the designated container (ARR), centrifuge (760G (2000-3000rpm) x 10 minutes) at room temperature, remove as much of the supernatant as possible, and submit the sediment after freezing it.
●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.
CONTAINER
ARR 旧容器記号 r A
滅菌ポリスピッツ
貯蔵方法：室温
supplementary information
対象遺伝子変異等と関連する医薬品
| BRAF V600E変異 | ダブラフェニブメシル酸塩及びトラメチニブ ジメチルスルホキシド付加物の併用投与 |
|---|---|
| EGFR L858R変異および EGFRエクソン19欠失変異 |
ゲフィチニブ、エルロチニブ塩酸塩、アファチニブマレイン酸塩、オシメルチニブメシル酸塩 |
| ALK融合遺伝子 | クリゾチニブ、アレクチニブ塩酸塩 |
| ROS1融合遺伝子 | クリゾチニブ、エヌトレクチニブ |
